Literature DB >> 2312954

The natural history of adults with asymptomatic, hemodynamically significant aortic stenosis.

P A Pellikka1, R A Nishimura, K R Bailey, A J Tajik.   

Abstract

The natural history of asymptomatic, hemodynamically significant, valvular aortic stenosis in adults was documented. Of 471 patients with aortic stenosis identified by Doppler echocardiography (peak systolic flow velocity greater than or equal to 4 m/s) from January 1984 through August 1987, 143 were asymptomatic and had isolated valvular aortic stenosis. Thirty patients underwent aortic valve intervention within 3 months (group 1); the remaining 113 patients did not have an intervention within 3 months (group 2). Follow-up information was available for all patients; the mean duration of follow-up study was 20 months (range 6 to 48). Three cardiac events occurred in the 30 group 1 patients after operation (two deaths, one reoperation). Among the 113 group 2 patients, three had cardiac death presumed to be a result of the aortic stenosis; all three developed symptoms at least 3 months before death. The actuarial probability of remaining free of symptoms of angina, dyspnea or syncope for group 2 was 86% at 1 year and 62% at 2 years. For this group, the 1 and 2 year probabilities of remaining free of cardiac events, including aortic valve intervention or cardiac death, were 93% and 74%, respectively. Of all clinical and echocardiographic variables (group 2), only Doppler flow velocity (p = 0.004) and ejection fraction (p = 0.01) were independent predictors of subsequent cardiac events. Among the 44 patients (groups 1 and 2) with a flow velocity greater than or equal to 4.5 m/s, the relative risk of sustaining a cardiac event (by Cox regression analysis) was 4.9 (p = 0.004).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1990        PMID: 2312954     DOI: 10.1016/0735-1097(90)90234-g

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  42 in total

1.  To operate or not on elderly patients with aortic stenosis: the decision and its consequences.

Authors:  B J Bouma; R B van Den Brink; J H van Der Meulen; H A Verheul; E C Cheriex; H P Hamer; E Dekker; K I Lie; J G Tijssen
Journal:  Heart       Date:  1999-08       Impact factor: 5.994

Review 2.  Pathophysiology of valvular heart disease: implications for nuclear imaging.

Authors:  Blasé Carabello
Journal:  J Nucl Cardiol       Date:  2002 Jan-Feb       Impact factor: 5.952

3.  Aortic Stenosis.

Authors: 
Journal:  Curr Treat Options Cardiovasc Med       Date:  2000-04

4.  Robert Ogden Bonow, MD: a conversation with the editor on valvular heart disease and indications for operative intervention. Interview by William Clifford Roberts.

Authors:  Robert Ogden Bonow
Journal:  Proc (Bayl Univ Med Cent)       Date:  2005-01

Review 5.  Aortic stenosis: medical and surgical management.

Authors:  Helmut Baumgartner
Journal:  Heart       Date:  2005-11       Impact factor: 5.994

Review 6.  [Aortic stenosis].

Authors:  W G Daniel; H Baumgartner; C Gohlke-Bärwolf; P Hanrath; D Horstkotte; K C Koch; A Mügge; H J Schäfers; F A Flachskampf
Journal:  Clin Res Cardiol       Date:  2006-11       Impact factor: 5.460

Review 7.  Asymptomatic valvular disease: who benefits from surgery?

Authors:  Naomi F Botkin; Paula S Seth; Gerard P Aurigemma
Journal:  Curr Cardiol Rep       Date:  2005-03       Impact factor: 2.931

Review 8.  Transcatheter aortic valve replacement: an update.

Authors:  Sharif A Halim; Todd L Kiefer; G Chad Hughes; Lynne M Hurwitz; J Kevin Harrison
Journal:  Curr Cardiol Rep       Date:  2013-06       Impact factor: 2.931

Review 9.  Natriuretic peptides in the management of aortic stenosis.

Authors:  Jutta Bergler-Klein
Journal:  Curr Cardiol Rep       Date:  2009-03       Impact factor: 2.931

10.  Asymptomatic severe aortic stenosis with left ventricular dysfunction: watchful waiting or valve replacement?

Authors:  Larry E Miller; Valerie M Miller; Larry D Acers
Journal:  Clin Med Res       Date:  2013-04-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.